Safrazine

Safrazine
Clinical data
Other names	4-benzo[1,3]dioxol-5-ylbutan-2-ylhydrazine; [3-(3,4-(methylenedioxy)phenyl)-1-butyl]hydrazine; 2-piperonylisopropylhydrazine
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name [3-(1,3-benzodioxol-5-yl)-1-methyl-propyl]hydrazine;
CAS Number	33419-68-0;
PubChem CID	34042;
ChemSpider	31375;
UNII	F5G0P5378C;
CompTox Dashboard (EPA)	DTXSID60860006 ;
Chemical and physical data
Formula	C11H16N2O2
Molar mass	208.261 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(CCc2ccc1OCOc1c2)NN;

Safrazine (Safra) is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class that was introduced as an antidepressant in the 1960s, but has since been discontinued.[1]

References

Morton I, Morton IK, Hall JM (31 October 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 251–. ISBN 978-0-7514-0499-9.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.